Nadim Ahmed
Nadim Ahmed has over 25 years of leadership experience in oncology development and commercialization. In his current role as CEO of Cullinan Oncology, Nadim oversees an expert team focused on creating new standards of care for patients with cancer through a modality-agnostic, targeted oncology approach to building a diversified pipeline of first-in-class and best-in-class therapeutics. Since joining the company in 2021, Nadim has helped Cullinan expand its pipeline from one asset in the clinic to an expected six assets in the clinic by the end of 2023.
He holds a Master of Science degree from Loughborough University, UK and a Bachelor of Science degree from University College London, UK. Nadim currently serves on the Board of Directors for Family Promise, a national non-profit organization helping families impacted by homelessness.
-
Now More Than Ever, Biopharma Must Embrace Boldness to Ride Out the Economic Storm
During my 25 years in oncologic drug discovery, development and commercialization, I have seen how economic cycles can skew priorities and slow progress – but we cannot let that happen.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
